We cannot vaccinate fast enough. To our advantage, though, many more vaccines are coming down the pipeline. Janssen and AstraZeneca will likely be available next, followed by Novavax which is about to start its research trial. If you’re like me, these are starting to get difficult to keep track of, so I started a Table for myself. It may (or may not) be helpful for you too. It's not very pretty, but I'm a researcher not a graphic designer :)
Vaccine Update
Vaccine Update
Vaccine Update
We cannot vaccinate fast enough. To our advantage, though, many more vaccines are coming down the pipeline. Janssen and AstraZeneca will likely be available next, followed by Novavax which is about to start its research trial. If you’re like me, these are starting to get difficult to keep track of, so I started a Table for myself. It may (or may not) be helpful for you too. It's not very pretty, but I'm a researcher not a graphic designer :)